Scott Coiante
2018
In 2018, Scott Coiante earned a total compensation of $872.7K as Sr. VP & Chief Financial Officer at Agile Therapeutics, a 37% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $70,700 |
| Option Awards | $296,680 |
| Salary | $321,400 |
| Stock Awards | $55,602 |
| Other | $28,353 |
| Total | $872,735 |
Coiante received $321.4K in salary, accounting for 37% of the total pay in 2018.
Coiante also received $100K in bonus, $70.7K in non-equity incentive plan, $296.7K in option awards, $55.6K in stock awards and $28.4K in other compensation.
Rankings
In 2018, Scott Coiante's compensation ranked 9,810th out of 14,244 executives tracked by ExecPay. In other words, Coiante earned more than 31.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,810 out of 14,244 | 31st |
Division Manufacturing | 3,961 out of 5,759 | 31st |
Major group Chemicals And Allied Products | 1,487 out of 2,122 | 30th |
Industry group Drugs | 1,252 out of 1,811 | 31st |
Industry Pharmaceutical Preparations | 962 out of 1,385 | 31st |
Source: SEC filing on April 25, 2019.
Coiante's colleagues
We found two more compensation records of executives who worked with Scott Coiante at Agile Therapeutics in 2018.